We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.4%
2 Technology 3.32%
3 Consumer Discretionary 2.87%
4 Financials 2.84%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTNB icon
8876
Matinas BioPharma
MTNB
$1.88M
$90K ﹤0.01%
+2,337
New +$89.6K
TZOO icon
8877
CALL
Travelzoo
TZOO
$74.3M
$90K ﹤0.01%
+16,000
New +$88.3K
RDGT
8878
Ridgetech Inc
RDGT
$2.74M
$90K ﹤0.01%
+2
New +$152K
JNCE
8879
CALL
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$90K ﹤0.01%
13,000
-1,500
-10% -$8.09K
DBRG icon
8880
CALL
DigitalBridge
DBRG
$2.93B
$89K ﹤0.01%
9,300
+2,025
+28% +$17.6K
GYRE icon
8881
PUT
Gyre Therapeutics
GYRE
$641M
$89K ﹤0.01%
2,013
-14
-0.7% -$657
ENLC
8882
PUT
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$89K ﹤0.01%
36,300
-7,100
-16% -$14.7K
SIEN
8883
CALL
DELISTED
Sientra, Inc.
SIEN
$89K ﹤0.01%
+2,290
New +$69.1K
RPT
8884
CALL
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$89K ﹤0.01%
12,800
-5,800
-31% -$36.9K
SPPI
8885
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$89K ﹤0.01%
26,200
-11,700
-31% -$34.1K
SOGO
8886
PUT
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$89K ﹤0.01%
21,200
-9,300
-30% -$33K
CVIA
8887
DELISTED
Covia Holdings Corporation Common Stock
CVIA
$89K ﹤0.01%
185,431
+149,376
+414% +$81.7K
MUX icon
8888
PUT
McEwen Inc
MUX
$1.03B
$88K ﹤0.01%
8,690
+1,590
+22% +$14.8K
RMTI icon
8889
PUT
Rockwell Medical
RMTI
$28.4M
$88K ﹤0.01%
410
+49
+14% +$11.6K
TEI
8890
Templeton Emerging Markets Income Fund
TEI
$314M
$88K ﹤0.01%
+11,195
New +$85.2K
UTI icon
8891
PUT
Universal Technical Institute
UTI
$2.16B
$88K ﹤0.01%
+12,700
New +$83.4K
ZVO
8892
DELISTED
Zovio Inc. Common Stock
ZVO
$88K ﹤0.01%
+28,612
New +$64.9K
SREV
8893
DELISTED
ServiceSource International, Inc.
SREV
$88K ﹤0.01%
55,934
+34,719
+164% +$47.4K
LAB icon
8894
CALL
Standard BioTools
LAB
$340M
$87K ﹤0.01%
+21,700
New +$75.6K
UUUU icon
8895
PUT
Energy Fuels
UUUU
$2.86B
$87K ﹤0.01%
57,300
+18,500
+48% +$29.4K
WORX
8896
DELISTED
SCWORX CORP NEW
WORX
$87K ﹤0.01%
+67
New +$73.7K
NOVN
8897
DELISTED
Novan, Inc. Common Stock
NOVN
$87K ﹤0.01%
+18,021
New +$76.3K
DBRG icon
8898
PUT
DigitalBridge
DBRG
$2.93B
$86K ﹤0.01%
8,950
-3,900
-30% -$33.8K
FCG icon
8899
PUT
First Trust Natural Gas ETF
FCG
$647M
$86K ﹤0.01%
+11,500
New +$82.2K
NHTC icon
8900
CALL
Natural Health Trends
NHTC
$14.7M
$86K ﹤0.01%
15,100
-900
-6% -$4.66K

Similar funds

Citadel Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.

  • Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
  • Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.